Smart People: Hilary Hutton-Squire
PharmaTimes talks to Hilary Hutton-Squire, vice president and general manager of Gilead Sciences in the UK and Ireland, about the importance of valuing medicines in the right way
PharmaTimes Magazine Archive
Magazine highlights
View more from the latest edition
A clearer picture
Marni Hall and Nicola Stanislaus look at the growing role of real-world evidence
Raising the bar
A 2019 review has shown that the current system for detecting cancer is failing to reach its potential. Fujifilm’s Adrian Waller says we need a more tech-enabled and patient-centred approach
The year of no Brexit (again)
Political uncertainty became endemic during 2019, despite a lot of government planning
2019 – the return of the mega deal?
Globally mega deals continue to abound, domestically the mid-market and PE have been the core drivers of activity
Unlocking value
How can 2020 be the year that R&D really delivers value, people get real about data, and pharma starts to develop even better medicines?
Bag to the future
For decades intrepid pharma sales forces navigated the road network of Great Britain with little more than paper, pen and personality – hoping that one day the tools of their trade would mirror the cutting-edge science of the products they showcased. In recent years, the digital era has truly arrived, but as 2020 looms, big challenges still remain
Going for gold
Who emerged victorious at this year’s Marketer of the Year, Communications Team of the Year and Sales competitions?
